Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma

  • Dominika Wolosz Medical University of Warsaw, Department of Pathology, Poland.
  • Agnieszka Walczak Polish Academy of Sciences, Nencki Institute of Experimental Biology - Adam Mickiewicz University, Department of Gene Expression, Poland.
  • Grzegorz Szparecki Medical University of Warsaw, Department of Pathology, Poland.
  • Michal Dwojak Medical University of Warsaw, Center for Biostructure Research, Poland.
  • Magdalena Winiarska Medical University of Warsaw, Center for Biostructure Research, Poland.
  • Ewa Wolinska | Ewa.Wolinska7@gmail.com Medical University of Warsaw, Department of Pathology, Poland.
  • Barbara Gornicka Medical University of Warsaw, Department of Pathology, Poland.

Abstract

Deleted in Liver Cancer (DLC) proteins belong to the family of RhoGAPs and are believed to operate as negative regulators of the Rho family of small GTPases. So far, the role of the first identified member from the DLC family, DLC1, was established as a tumor suppressor in hepatocellular carcinoma. The function of its close family relative, DLC2 is unequivocal. In the present study we attempted to determine whether the loss of DLC2 is a common feature of hepatocellular carcinoma tissue. We examined two types of hepatocellular carcinoma- typical and fibrolamellar one. Our analysis revealed that DLC2 protein is not diminished in cancer tissue when compared to non-cancerous liver specimens. What is more, we observed DLC2 to be more abundantly expressed in cancer tissue, particularly in tumors with the inflammation background. In addition, we found that DLC2 gene status was diploid in virtually all tumor samples examined. Our results indicate that DLC2 is not diminished in hepatocellular carcinoma cells. It appears that members of the DLC family, although structurally highly related, may function differently in cancer cells.

Downloads

Download data is not yet available.
Published
2019-02-18
Section
Original Papers
Supporting Agencies
Polish State Committee for Scientific Research, Medical University of Warsaw, Poland
Keywords:
DLC2, hepatocellular carcinoma, fibrolamellar hepatocellular carcinoma
Statistics
Abstract views: 293

PDF: 119
HTML: 10
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Wolosz, D., Walczak, A., Szparecki, G., Dwojak, M., Winiarska, M., Wolinska, E., & Gornicka, B. (2019). Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma. European Journal of Histochemistry, 63(1). https://doi.org/10.4081/ejh.2019.2981